{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:43:56Z","timestamp":1759693436467,"version":"build-2065373602"},"reference-count":12,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.mehy.2012.10.015","type":"journal-article","created":{"date-parts":[[2012,11,11]],"date-time":"2012-11-11T05:45:17Z","timestamp":1352612717000},"page":"65-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Organ specific complement proteins inhibition can reduce the risk of antiphospholipid antibodies mediated fetal loss"],"prefix":"10.1016","volume":"80","author":[{"given":"Annamalai","family":"Amarnath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Govindaraju","family":"Archunan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2012.10.015_b0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0095-5108(18)30168-4","article-title":"Autoimmune disease in pregnancy. Systemic lupus erythematosus and antiphospholipid syndrome","volume":"24","author":"Silver","year":"1997","journal-title":"Clin Perinatol"},{"key":"10.1016\/j.mehy.2012.10.015_b0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1006\/jaut.2000.0409","article-title":"Epidemiology of the antiphospholipid antibody syndrome","volume":"15","author":"Petri","year":"2000","journal-title":"J Autoimmun"},{"key":"10.1016\/j.mehy.2012.10.015_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jri.2007.02.007","article-title":"Antiphospholipid antibodies and pregnancy loss: a disorder of inflammation","volume":"77","author":"Salmon","year":"2008","journal-title":"J Reprod Immunol"},{"key":"10.1016\/j.mehy.2012.10.015_b0020","doi-asserted-by":"crossref","first-page":"4375","DOI":"10.1182\/blood-2005-07-2636","article-title":"Autoantibodies against the fibrinolytic receptor, annexin 2, in antiphospholipid syndrome","volume":"107","author":"Cesarman-Maus","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2012.10.015_b0025","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/ncprheum0432","article-title":"The antiphospholipid syndrome as a disorder initiated by inflammation: implications for the therapy of pregnant patients","volume":"3","author":"Salmon","year":"2007","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.mehy.2012.10.015_b0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1196\/annals.1361.083","article-title":"Complement activation: a novel pathogenic mechanism in the antiphospholipid syndrome","volume":"1051","author":"Pierangeli","year":"2005","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.mehy.2012.10.015_b0035","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1182\/blood-2007-01-070631","article-title":"Tissue factor: a link between C5a and neutrophil activation in antiphospholipid antibody induced fetal injury","volume":"110","author":"Redecha","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.mehy.2012.10.015_b0040","first-page":"3453","article-title":"Neutrophil activation by the tissue factor\/Factor VIIa\/PAR2 axis mediates fetal death in a mouse model of antiphospholipid syndrome","volume":"118","author":"Redecha","year":"2008","journal-title":"J Clin Investig"},{"key":"10.1016\/j.mehy.2012.10.015_b0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12016-009-8187-1","article-title":"Role of tissue factor in the maternal immunological attack of the embryo in the antiphospholipid syndrome","volume":"39","author":"Girardi","year":"2010","journal-title":"Clin Rev Allergy Immunol"},{"issue":"Suppl. 2","key":"10.1016\/j.mehy.2012.10.015_b0050","doi-asserted-by":"crossref","first-page":"ii46","DOI":"10.1136\/ard.61.suppl_2.ii46","article-title":"Complement activation as a mediator of antiphospholipid antibody induced pregnancy loss and thrombosis","volume":"61","author":"Salmon","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.mehy.2012.10.015_b0055","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1002\/art.21157","article-title":"Requirement of activation of complement C3 and C5 for antiphospholipid antibody-mediated thrombophilia","volume":"52","author":"Pierangeli","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.mehy.2012.10.015_b0060","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1038\/nm1121","article-title":"Heparin prevents antiphospholipid antibody-induced fetal loss by inhibiting complement activation","volume":"10","author":"Girardi","year":"2004","journal-title":"Nat Med"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712004665?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987712004665?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:13:15Z","timestamp":1759691595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987712004665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":12,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0306987712004665"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2012.10.015","relation":{},"ISSN":["0306-9877"],"issn-type":[{"type":"print","value":"0306-9877"}],"subject":[],"published":{"date-parts":[[2013,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organ specific complement proteins inhibition can reduce the risk of antiphospholipid antibodies mediated fetal loss","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2012.10.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}